Key facts
- This page summarizes Peter M. Hecht's Form 4 filing for Cyclerion Therapeutics, Inc. (CYCN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2025, 20:38.
Peter M. Hecht - 25 Mar 2025 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- CYCN
- Reported as of
- 25 Mar 2025
- Net transaction value
- +$500,000
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2025, 20:38:03 UTC
- Prior SEC filing
- 26 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter M. Hecht
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter M. Hecht filed Form 4 for Cyclerion Therapeutics, Inc. (CYCN) on 27 Mar 2025.
Change
- Previous filing in this sequence was filed on 26 Jan 2024.
- Current net transaction value: +$500,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYCN
transaction
Common Stock
Award
- Transaction value
- $500,000
- Shares
- +181,818
- Change %
- +48%
- Price
- $2.75
- Shares after
- 559,203
- Date
- 25 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
CYCN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 24
- Date
- 25 Mar 2025
- Ownership
- The 2000 Trust for Alexis Mae Hecht
- Footnotes
- F2
CYCN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 24
- Date
- 25 Mar 2025
- Ownership
- The 2000 Trust for Malcolm Peter Hecht
- Footnotes
- F2
CYCN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 24
- Date
- 25 Mar 2025
- Ownership
- The 2000 Trust for Zoe Niovi Hecht
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On March 25, 2025, the reporting person purchased directly from the Issuer 181,818 shares of Common Stock for a total purchase price of approximately $500,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein.
Footnote F2
These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.